Drug firm Lupin on Saturday said it has received two observations from the US health regulator following the inspection of its Nagpur manufacturing f
from Business Line - Companies https://ift.tt/309eDpi
from Business Line - Companies https://ift.tt/309eDpi
Comments
Post a Comment